Type 4 drugs act via unknown mechanisms and include isoniazid (INH), methyldopa, captopril, tricyclic antidepressants (TCAD), diazepam, heroin and cannabis.6,7 Spironolactone is a steroidal antimineralocorticoid and is one of the medications that have been most linked with gynecomastia. Gynecomastia can be typically classified into four grades of increasing severity, from I to IV, ranging from simple areolar protrusion, to breasts with a female appearance. It usually regresses within 18m and is uncommon in males aged 17 and older.8,11 The final peak occurs in older males (particularly in those aged years-old), with a prevalence of 24-65%.
Testosterone also can be converted to oestradiol by the enzyme aromatase, found especially in adipose tissue. Testicular Leydig cells produce 95% of testosterone. Our PCT Stack includes everything needed for comprehensive estrogen management. Consider your genetic predisposition — family history of gyno or high estrogen sensitivity means more aggressive prevention. Post-surgery, maintain proper estrogen control to prevent recurrence.
Increased stress can stimulate the adrenal glands to secrete excess estrogen precursors. After dialysis, patients are free to resume a regular diet and often regain weight. Before dialysis, renal failure patients have restricted diets, can be malnourished and tend to lose weight. Gynecomastia is observed in approximately 50% of hemodialysis patients, primarily due to Leydig cell dysfunction. In addition, SHBG is often increased, leading to increased concentrations of E2.
If you’re concerned about how long you’ve had gynecomastia or it’s causing you distress, reach out to your healthcare provider. Days may feel like weeks when you’re living with gynecomastia, especially if it’s affecting how you view yourself. Substances, including amphetamines, marijuana and heroin, may also cause gynecomastia.
Malnourishment can cause gynecomastia due to decreased gonadotropin and T levels, coupled with normal production of estrogens (and their precursors) from the adrenal glands. Spironolactone is also used to treat cirrhotic patients, which can exacerbate the condition.11,15 Alcohol use can also disrupt the hypothalamic–pituitary–testicular axis, causing a decrease in serum T levels. Interestingly, more than half of the patients with persistent pubertal gynecomastia have a family history of the condition.
It also binds to the androgen receptor, blocking the binding of T and DHT, or displacing them from their receptors. Type 2 causes include gonadotropins, clomiphene and enhanced endogenous estrogen, type 3 include metronidazole, cimetidine, flutamide, cyproterone acetate and bicalutamide. The role of PRL, progesterone and other growth factors (GFs) such as insulin like growth factor I (IGF-I) and epidermal growth factor (EGF), in the development of gynecomastia are unclear.
Importantly, there is also a growing body of evidence supporting the utility of this class of drugs in gynecomastia, particularly Tmx.21,22,23,24 Tmx is an estrogen antagonist, and is a well-tolerated, reliable and non-toxic agent. Although clinical data are limited, more studies have determined the efficacy of anti-estrogens compared with other gynecomastia therapies. Several agents regulate the hormonal imbalance that is thought to cause the gynecomastia. The duration of gynecomastia is a major factor affecting the initial approach to treatment. If gynecomastia is drug induced, symptoms may regress when the causative medication is stopped or changed.5,6,11 Systemic illness-related gynecomastia regresses with the treatment of these disorders (for example the treatment of hyperthyroidism, or surgical removal of testicular, adrenal, or other causative tumors may lead to regression). Before beginning treatment, the patient must be informed that these cases are usually benign and self-limiting and that over time fibrotic tissue replaces the symptomatic proliferation of glandular tissue, meaning that the pain and tenderness will resolve.
Gynecomastia caused by transient changes in hormone levels with growth usually disappears on its own within six months to two years. Gynecomastia is different from pseudogynecomastia or lipomastia, which refers to the presence of fat deposits in the breast area of obese men. While Gynaecomastia can appear in males of any age, there are several factors that make you more likely to have Gynaecomastia.